Keyphrases
ATP-competitive
20%
Cancer Treatment
20%
CDK7
20%
Cdks
100%
Cell Cycle Arrest
20%
Control Process
20%
Cyclin-dependent Kinase
20%
Cyclin-dependent Kinase 1 (CDK1)
20%
Cyclin-dependent Kinase 2 (CDK2)
40%
Cyclin-dependent Kinase 4 (CDK4)
20%
Cyclin-dependent Kinase 9 (CDK9)
20%
Cyclin-dependent Kinase Inhibitor
100%
Cytostatic Effect
20%
Decreased Expression
20%
Direct Induction
20%
Drug-induced
20%
High-throughput
20%
In Silico Screening
20%
Kinase Family
20%
Mechanism of Action
20%
Molecular Docking
100%
Multiple Lines of Evidence
20%
Novel Class
100%
Protein Aggregation
20%
Protein Level
20%
Rb Phosphorylation
20%
Small Molecules
20%
Therapeutic Target
20%
Unique Mechanism
100%
Biochemistry, Genetics and Molecular Biology
Adenosine Triphosphate
25%
Cell Cycle
100%
Cell Cycle Arrest
25%
Cell Cycle Checkpoint
25%
Cyclin-Dependent Kinase
100%
Cyclin-Dependent Kinase 2
25%
Cyclin-Dependent Kinase 4
25%
Docking (Molecular)
100%
E2F
25%
Protein Aggregation
25%
Small Molecule
25%
Transcription
25%
Pharmacology, Toxicology and Pharmaceutical Science
Adenosine Triphosphate
50%
Cyclin Dependent Kinase
50%
Cyclin Dependent Kinase 2
50%
Cyclin Dependent Kinase 4
50%
Cyclin Dependent Kinase Inhibitor
100%
Cytostatic Agent
50%
Malignant Neoplasm
50%